Gene signatures of drug resistance predict patient survival in colorectal cancer

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

(2012) Ligia Traldi Macedo et al.   BMC CANCER

Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

(2012) Beatriz Perez Villamil et al.   BMC CANCER

Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis

(2012) Jian Chen et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis

(2012) T. Joyce et al.   CURRENT CANCER DRUG TARGETS

Gene Expression Profiling of Peritoneal Metastases from Appendiceal and Colon Cancer Demonstrates Unique Biologic Signatures and Predicts Patient Outcomes

(2012) Edward A. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

(2012) Y Zheng et al.   LEUKEMIA

Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells

(2012) W. L. Allen et al.   MOLECULAR CANCER THERAPEUTICS

CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines

(2012) Manuele Giuseppe Muraro et al.   Stem Cells Translational Medicine

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia

(2011) W. Warsch et al.   BLOOD

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

(2011) D Bose et al.   BRITISH JOURNAL OF CANCER

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity

(2011) Joseph R. Bertino et al.   CANCER BIOLOGY & THERAPY

Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer

(2011) Thomas H. Cartwright   Clinical Colorectal Cancer

Oxaliplatin: a review in the era of molecularly targeted therapy

(2011) T. Alcindor et al.   Current Oncology

Expression and function of epithelial anoctamins

(2011) Karl Kunzelmann et al.   EXPERIMENTAL PHYSIOLOGY

Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology

(2011) J. W. Cain et al.   MOLECULAR CANCER RESEARCH

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation

(2011) Yunguang Tong et al.   MOLECULAR ENDOCRINOLOGY

SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells

(2011) Daan van Abel et al.   PLoS One

Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer

(2011) Niels Frank Jensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Zhx2 and Zbtb20: Novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer

(2011) Martha L. Peterson et al.   SEMINARS IN CANCER BIOLOGY

Regulation of microtubule dynamics by TOG-domain proteins XMAP215/Dis1 and CLASP

(2011) Jawdat Al-Bassam et al.   TRENDS IN CELL BIOLOGY

Fanconi Anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments

(2010) Lisa A. Kachnic et al.   CANCER LETTERS

Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner

(2010) Teodora Pene-Dumitrescu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

(2009) R. N. Jorissen et al.   CLINICAL CANCER RESEARCH

Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

(2009) J. Joshua Smith et al.   GASTROENTEROLOGY

Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells

(2009) Kazutoshi Komiya et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer

(2009) A. Martinez-Cardus et al.   MOLECULAR CANCER THERAPEUTICS

Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway

(2009) Melanie S. Flint et al.   PSYCHONEUROENDOCRINOLOGY

Ubiquitin-Conjugating Enzyme UBE2D2 Is Responsible for FBXW2 (F-Box and WD Repeat Domain Containing 2)-Mediated Human GCM1 (Glial Cell Missing Homolog 1) Ubiquitination and Degradation1

(2008) Meng-Hsiu Chiang et al.   BIOLOGY OF REPRODUCTION

Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast Cancer

(2008) C. O'Brien et al.   CANCER RESEARCH

Intestinal adenomagenesis involves core molecular signatures of the epithelial–mesenchymal transition

(2008) Xiaodi Chen et al.   JOURNAL OF MOLECULAR HISTOLOGY

Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells

(2008) R. C-Y. Hui et al.   MOLECULAR CANCER THERAPEUTICS